2025/1589 - NINTEDANIB [100MG CÁPS]
TED · 504284-2026Award noticeawardedNo deadline given
Value
Estimated€17,200 · 17,199.75 EUR
Awarded—
WinnerBoehringer Ingelheim Portugal, Lda
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 17 | — | 2026-07-21 |
| GILEAD SCIENCES, LDA | 16 | — | 2026-07-21 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 11 | €1,569,649 | 2026-07-14 |
| NOVARTIS FARMA - PROD.FARM SA | 9 | — | 2026-06-30 |
| AMGEN BIOFARMACEUTICA, LDA | 8 | €396,644 | 2026-06-24 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
NINTEDANIB [100MG CÁPS]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-21 | 2025/1589 - NINTEDANIB [100MG CÁPS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-07-14 | 2025/1589 - NINTEDANIB [150MG CÁPS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 99% |
| 2026-06-09 | 2025/1589 -MOMELOTINIB [200 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-05-12 | 2025/1589 - MARIBAVIR [200 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-06-30 | 2025/1303 - ENTECAVIR [0.5 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-07-07 | 2023/0491 - VENETOCLAX [100 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |